Paul Liguori, MD
Physical Medicine & Rehabilitation · Bradford, MANPI 1700826237
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 33.4% of the total. 2025 is the largest year on record at $280, 4.0 times the $69 reported in 2019.
Across 39 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$295
- Smith+Nephew$198
- Merz Pharmaceuticals, LLC$104
- Medline Industries LP$68
- Coloplast$42
- Solventum Corporation$37
- plus $140 from 6 others
What the payments were for
- Food & beverage$885100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $295 |
| Smith+Nephew | 9 | $198 |
| Merz Pharmaceuticals, LLC | 4 | $104 |
| Medline Industries LP | 3 | $68 |
| Coloplast | 2 | $42 |
| Solventum Corporation | 1 | $37 |
| Aroa Biosurgery Incorporated | 3 | $33 |
| Organogenesis Inc. | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Novo Nordisk | 1 | $23 |
| Medtronic | 1 | $21 |
| Dynasplint Systems Inc. | 1 | $10 |
How this compares
$885 in reported general payments places this provider in the 75th percentile of 244 physical medicine & rehabilitation providers in Massachusetts.
See all physical medicine & rehabilitation providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 129 | $4,402 |
| Donepezil Hcl | 338 | $2,951 |
| Gentamicin Sulfate | 43 | $2,316 |
| Mupirocin | 99 | $1,382 |
| Doxycycline Hyclate | 31 | $402 |
| CiclopiroxCiclopirox Olamine | 16 | $320 |
| Ciprofloxacin Hcl | 18 | $269 |
| Sertraline Hcl | 17 | $120 |
| Triamcinolone Acetonide | 14 | $81 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Bradford
- Zachary BohartBurlington$633K
- Sabrina PaganoniCharlestown$80K
- Walter SussmanWellesley$50K
- Stephen KoelbelWeymouth$24K
- Moorice CaparoCharlestown$18K
- Didem InanogluBoston$13K
- Andrew DuarteWorcester$8K
- Jenna MeriggiHaverhill$6K
- Jerry Chi Chuan FangBrockton$5K
- Kevin BernardPeabody$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.